Older News Items
12th-October-2020
Vascular Function, Tau, and Alzheimers
9th-October-2020
Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
6th-October-2020
Increasing PICALM expression reverses endocytic defects in APOE4 astrocytes in AD
1st-October-2020
P11 deficiency increases stress reactivity
28th-September-2020
Epigenetic alterations associated with Alzheimer’s disease
17th-September-2020
Function of WFS1 and WFS2 in the Central Nervous System
11th-September-2020
Cerebral Fructose Metabolism as a Potential Mechanism Driving AD
2nd-September-2020
A mechanism by which inflammation affects the generation of amyloid-beta in AD
22nd-August-2020
7th-August-2020
Identification of VGF as a key regulator in Alzheimer’s Disease
28th-July-2020
p-tau217 blood test for early detection of AD
21st-July-2020
CMS121 protects against cognitive loss in Mouse model of Alzheimers
13th-July-2020
SRPX2 protects against complement-mediated synapse loss
12th-July-2020
Oxytocin reverses Aβ-induced impairment of hippocampal synaptic plasticity in mice
10th-July-2020
BACE2 identified as AD suppressor using cerebral organoid assay